This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

23 Jul 2012

TPG Set to Buy Par Pharmaceuticals

Generic drug maker Par Pharmaceuticals has agreed to be bought for $1.9 billion by TPG.

Private equity group TPG has agreed to purchase Par Pharmaceuticals for $1.9 billion, with shareholders receiving $50 per share in cash.


This represents a 37 per cent premium above the generic drug maker's closing share price on July 13th 2012.


Related News